| Drug Type Fusion protein | 
| Synonyms- | 
| Target | 
| Action modulators, agonists | 
| Mechanism GDF15 modulators(Growth/differentiation factor 15 modulators), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Obesity | Preclinical | China  | 09 Feb 2023 | 






